Literature DB >> 7882471

Angiotensin-converting enzyme genotype in children and coronary events in their grandparents.

R F Badenhop1, X L Wang, D E Wilcken.   

Abstract

BACKGROUND: It has been suggested that the insertion/deletion (I/D) polymorphism of the angiotensin-converting enzyme (ACE) gene is an independent risk factor for coronary artery disease. The D/D genotype, which is associated with higher levels of circulating ACE than the I/D or I/I genotype, has been found significantly more frequently in patients with myocardial infarction and also in individuals with a parental history of myocardial infarction. METHODS AND
RESULTS: We explored the distribution of the ACE genotype in 404 school children, aged 6 to 13 years, and related the distribution to the number of their grandparents who had had vascular events. We found a significant association between the number of grandparents who had had coronary events and the ACE genotype (P = .01). In children with two or more grandparents who had had coronary events, there was an excess of both D/D (odds ratio = 2.8 [95% confidence interval = 1.16-6.56]) and I/D (odds ratio = 1.4 [95% confidence interval = 0.62-3.25]) genotypes compared with I/I genotypes. In addition, there was an association between the ACE genotype and lipoprotein(a) levels in children (P = .07). Both the ACE genotype and lipoprotein(a) were found to contribute significantly (P = .0042) and independently to family history of coronary artery disease, with the ACE genotype proving to be more predictive than lipoprotein(a) levels.
CONCLUSIONS: We conclude that the I/D polymorphism of the ACE gene is an important independent risk factor for coronary artery disease and is more predictive that lipoprotein(a). The I/D polymorphism is not only associated with a parental history of myocardial infarction but also with coronary artery disease in second-degree relatives. A further study to explore the relation between the I/D polymorphism and circulating levels of lipoprotein(a) is indicated.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7882471     DOI: 10.1161/01.cir.91.6.1655

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  11 in total

Review 1.  Angiotensin I-converting enzyme: genotype and disease associations.

Authors:  D Crisan; J Carr
Journal:  J Mol Diagn       Date:  2000-08       Impact factor: 5.568

2.  Associations between circulating components of the renin-angiotensin-aldosterone system and left ventricular mass.

Authors:  H Schunkert; H W Hense; M Muscholl; A Luchner; S Kürzinger; A H Danser; G A Riegger
Journal:  Heart       Date:  1997-01       Impact factor: 5.994

3.  Randomised controlled trial of dual blockade of renin-angiotensin system in patients with hypertension, microalbuminuria, and non-insulin dependent diabetes: the candesartan and lisinopril microalbuminuria (CALM) study.

Authors:  C E Mogensen; S Neldam; I Tikkanen; S Oren; R Viskoper; R W Watts; M E Cooper
Journal:  BMJ       Date:  2000-12-09

4.  Contribution of genetic polymorphism in the renin-angiotensin system to the development of renal complications in insulin-dependent diabetes: Genetique de la Nephropathie Diabetique (GENEDIAB) study group.

Authors:  M Marre; X Jeunemaitre; Y Gallois; M Rodier; G Chatellier; C Sert; L Dusselier; Z Kahal; L Chaillous; S Halimi; A Muller; H Sackmann; B Bauduceau; F Bled; P Passa; F Alhenc-Gelas
Journal:  J Clin Invest       Date:  1997-04-01       Impact factor: 14.808

5.  Angiotensin-Converting Enzyme Gene Polymorphism and Plasminogen Activator Inhibitor 1 Levels in Subjects with Cerebral Infarction.

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1998-07       Impact factor: 2.300

Review 6.  Role of the renin-angiotensin system as a risk factor for control of morbidity and mortality in coronary artery disease.

Authors:  G A Riegger
Journal:  Cardiovasc Drugs Ther       Date:  1996-11       Impact factor: 3.727

Review 7.  Angiotensin-converting enzyme inhibitors and coronary artery disease.

Authors:  J W Sayer; A D Timmis
Journal:  Cardiovasc Drugs Ther       Date:  1996-11       Impact factor: 3.727

Review 8.  Adaptive and genetic alterations of the renin angiotensin system in cardiac hypertrophy and failure.

Authors:  S R Holmer; H Schunkert
Journal:  Basic Res Cardiol       Date:  1996       Impact factor: 17.165

Review 9.  Overview of inherited metabolic disorders causing cardiovascular disease.

Authors:  D E L Wilcken
Journal:  J Inherit Metab Dis       Date:  2003       Impact factor: 4.982

10.  The ACE gene insertion/deletion polymorphism and elite endurance swimming.

Authors:  Georgios Tsianos; Julie Sanders; Sukhbir Dhamrait; Steve Humphries; Stan Grant; Hugh Montgomery
Journal:  Eur J Appl Physiol       Date:  2004-05-08       Impact factor: 3.078

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.